Articles From: 2014/9/1 - Kering's Head of Sergio Rossi Shoes Steps Down to - Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe


2014/9/1
By Ruth Bender PARIS--Kering SA Monday said the chief executive of its shoe designer brand Sergio Rossi is stepping down to pursue other interests outside of the French luxury house.
Sign-up for 2014/9/1 - Kering's Head of Sergio Rossi Shoes Steps Down investment picks
2014/9/1
GLOSTRUP, Denmark, Sept.
Sign-up for 2014/9/1 - Dako Launches Fast HER2 ISH Assay for New Automated Staining Platform in Europe investment picks
2014/9/1
By Nikhil Lohade DUBAI--Emirates NBD (EMIRATES.DFM), Dubai's biggest lender, plans to meet fixed-income investors in the Middle East, Asia and Europe starting this week and may issue a benchmark-sized, U.S. dollar bond, after gauging demand, according to an arranging bank.
Sign-up for 2014/9/1 - Dubai's Emirates NBD Plans Benchmark Bond Sale - Source investment picks
2014/9/1
LONDON--Advertising firm WPP PLC (WPP.LN) said Monday that its majority-owned company, Aqua, has acquired Applogix, a marketing and ecommerce technology company in South Africa for an undisclosed sum.
Sign-up for 2014/9/1 - WPP's Aqua Acquires Applogix in South Africa for Undisclosed Sum investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141281&ProfileId=051205&sourceType=1 HONG KONG, CHINA --
Sign-up for - NetDimensions to Showcase at Stock Market Show investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed after treatment with docetaxel as well as abiraterone and/or enzalutamide.
Sign-up for - Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Here are some of the stocks that made notable moves in European trade Monday.
Sign-up for 2014/9/1 - EUROPE MARKETS: Novartis Up, Iliad Drops: European Movers investment picks
2014/9/1
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0964920005&sourceType=1 http://www.ccnmatthews.com/logos/20051006-BMO170.jpg http://www.ccnmatthews.com/logos/20051024-bmo_bank_logo.gif TORONTO, ONTARIO --
Sign-up for 2014/9/1 - REPEAT-Annual BMO Labour Day Survey: How Are Canadian Businesses Retaining Talented Employees? investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European markets turned lower after a Russia's foreign minister said Moscow will defend the economy if it comes up against another round of sanctions related to the conflict in Ukraine.
Sign-up for 2014/9/1 - EUROPE MARKETS: European Stocks Slip As Ukraine-Russia Tensions Heat Up investment picks
2014/9/1
By Marcin Sobczyk WARSAW--PKO Bank Polski SA (PKO.WA), Poland's top bank by assets, Monday said its second-quarter net profit rose 14% in annual terms driven by fast-growing interest income.
Sign-up for 2014/9/1 - Poland's PKO Bank Polski Posts 14% Rise in Annual 2Q Net Profit investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141282&ProfileId=051205&sourceType=1 HONG KONG, CHINA --
Sign-up for - NetDimensions (Holdings) Limited: Presenting at Annual Global Investment Conference investment picks
http://media.marketwire.com/attachments/201405/74802_formfactor.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141242&ProfileId=051205&sourceType=1 LIVERMORE, CA --
Sign-up for - FormFactor, Inc. Raises Third Quarter Guidance Range investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- Here are some of the stocks that made notable moves in European trade Monday.
Sign-up for 2014/9/1 - Novartis up, Iliad drops: European movers investment picks
2014/9/1
By Quentin Fottrell, MarketWatch Airlines get a bad rap from customers over delayed flights, high prices and baggage fees.
Sign-up for 2014/9/1 - UPDATE: The worst thing about flying? These people investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European markets turned lower after a Russia's foreign minister said Moscow will defend the economy if it comes up against another round of sanctions related to the conflict in Ukraine.
Sign-up for 2014/9/1 - UPDATE: European stocks slip as Ukraine-Russia tensions heat up investment picks
By Razak Musah Baba LONDON --
Sign-up for - Heineken sells Mexican can maker to Crown for $1.23 billion investment picks
By Grace Zhu BEIJING --
Sign-up for - China state banks report surge in soured loans investment picks
2014/9/1
By Josie Cox The Russian ruble hit a fresh record low against the U.S. dollar Monday, burned by continuing fighting in Ukraine over the weekend and European Commission President José Manuel Barroso warning that the situation was approaching "a point of no return." The dollar rose by 1.2% to 37.50 against the ruble in early trade, surpassing the previous record set on Friday.
Sign-up for 2014/9/1 - Ruble Hits New Record Low Against Dollar investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European markets turned lower after a Russia's foreign minister said Moscow will defend the economy if it comes up against another round of sanctions related to the conflict in Ukraine.
Sign-up for 2014/9/1 - EUROPE MARKETS: European Stocks Slip As Ukraine-Russian Tensions Escalate investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141287&ProfileId=051205&sourceType=1 HONG KONG, CHINA --
Sign-up for - NetDimensions (Holdings) Limited: Presenting at the 2014 Gateway Conference investment picks
2014/9/1
By Cris Larano MANILA--Philippine property group SM Prime Holdings Inc. (SMPH.PH) said Monday it has increased the size of its bond issue to 20 billion pesos ($458 million) in response to strong demand for its maiden retail bond offer.
Sign-up for 2014/9/1 - SM Prime Increases Retail Bond Size to PHP20 Billion investment picks
2014/09/01
While hybrid life/long-term care policies offer flexibility, today's purchasers could be fighting the last war.
Sign-up for 2014/09/01 - Are Long-Term Care Insurance Hybrids All They're Cracked Up to Be? investment picks
2014/9/1
Fitch Ratings Maintains Ecopetrol S.A.'s International and Local Ratings Canada NewsWire BOGOTA, Colombia , Sept.
Sign-up for 2014/9/1 - Fitch Ratings Maintains Ecopetrol S.A.'s International and Local Ratings investment picks
2014/9/1
U.K. utility SSE PLC (SSE.LN) said Monday it sold SSE Pipelines Ltd, an independent gas transporter, to the Environmental Capital Fund, a new fund managed by Scottish Equity Partners, for an estimated 52.7 million pounds ($87.6 million). The disposal of the unit, which provides gas connections to new residential and commercial developments across the U.K., is part of a program of asset and business sales announced earlier this year, SSE said.
Sign-up for 2014/9/1 - SSE Sells Gas Connections Unit to SEP Fund For GBP52.7 Million investment picks
2014/9/1
By Ian Walker LONDON--Direct Line Insurance Group PLC (DLG.LN) is expected to be promoted to the FTSE 100 index for the first time since it floated in October 2012, replacing can maker Rexam PLC (REX.LN), based on indicative data from FTSE International Monday.
Sign-up for 2014/9/1 - Direct Line to Join Top Flight in Latest Reshuffle investment picks
2014/9/1
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European markets turned lower after a Russia's foreign minister said Moscow will defend the economy if it comes up against another round of sanctions related to the conflict in Ukraine.
Sign-up for 2014/9/1 - European stocks slip as Ukraine-Russian tensions escalate investment picks
TEL-AVIV, Israel, Sept.
Sign-up for - Gazit-Globe Declares a Dividend of NIS 0.45 Per Share investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for - Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: 2014/9/1 - Kering's Head of Sergio Rossi Shoes Steps Down to - Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices